These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 15522281)

  • 21. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine.
    Iwanaga K; Takano H; Ohtsuka M; Hasegawa H; Zou Y; Qin Y; Odaka K; Hiroshima K; Tadokoro H; Komuro I
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1353-9. PubMed ID: 15555576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dihydroxyflavonol reduces post-infarction left ventricular remodeling by preventing myocyte apoptosis in the non-infarcted zone in goats.
    Wang S; Fei K; Xu YW; Wang LX; Chen YQ
    Chin Med J (Engl); 2009 Jan; 122(1):61-7. PubMed ID: 19187619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
    Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
    Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of collateral artery growth and improvement of post-infarct heart function by hepatocyte growth factor gene transfer.
    Wang W; Yang ZJ; Ma DC; Wang LS; Xu SL; Zhang YR; Cao KJ; Zhang FM; Ma WZ
    Acta Pharmacol Sin; 2006 May; 27(5):555-60. PubMed ID: 16626510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early treatment with hepatocyte growth factor improves cardiac function in experimental heart failure induced by myocardial infarction.
    Jin H; Yang R; Li W; Ogasawara AK; Schwall R; Eberhard DA; Zheng Z; Kahn D; Paoni NF
    J Pharmacol Exp Ther; 2003 Feb; 304(2):654-60. PubMed ID: 12538818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?
    Engberding N; Spiekermann S; Schaefer A; Heineke A; Wiencke A; Müller M; Fuchs M; Hilfiker-Kleiner D; Hornig B; Drexler H; Landmesser U
    Circulation; 2004 Oct; 110(15):2175-9. PubMed ID: 15466649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling.
    Wang X; Hu Q; Nakamura Y; Lee J; Zhang G; From AH; Zhang J
    Stem Cells; 2006 Jul; 24(7):1779-88. PubMed ID: 16614004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction.
    Xiao J; Moon M; Yan L; Nian M; Zhang Y; Liu C; Lu J; Guan H; Chen M; Jiang D; Jiang H; Liu PP; Li H
    Basic Res Cardiol; 2012 Jan; 107(1):239. PubMed ID: 22202974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of combined therapy of granulocyte colony stimulating factor and bone marrow mesenchymal stem cells carrying hepatocyte growth factor gene on angiogenesis of myocardial infarction in rats].
    Guo Y; Liu C; He J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jun; 25(6):736-40. PubMed ID: 21735790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure.
    Jayasankar V; Woo YJ; Bish LT; Pirolli TJ; Chatterjee S; Berry MF; Burdick J; Gardner TJ; Sweeney HL
    Circulation; 2003 Sep; 108 Suppl 1():II230-6. PubMed ID: 12970238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair.
    Kobayashi H; Minatoguchi S; Yasuda S; Bao N; Kawamura I; Iwasa M; Yamaki T; Sumi S; Misao Y; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Tabata Y; Fujiwara H
    Cardiovasc Res; 2008 Sep; 79(4):611-20. PubMed ID: 18541523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction.
    Kondo I; Ohmori K; Oshita A; Takeuchi H; Fuke S; Shinomiya K; Noma T; Namba T; Kohno M
    J Am Coll Cardiol; 2004 Aug; 44(3):644-53. PubMed ID: 15358035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart.
    Winter EM; Grauss RW; Hogers B; van Tuyn J; van der Geest R; Lie-Venema H; Steijn RV; Maas S; DeRuiter MC; deVries AA; Steendijk P; Doevendans PA; van der Laarse A; Poelmann RE; Schalij MJ; Atsma DE; Gittenberger-de Groot AC
    Circulation; 2007 Aug; 116(8):917-27. PubMed ID: 17684151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
    Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
    Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats.
    Dai W; Gerczuk P; Zhang Y; Smith L; Kopyov O; Kay GL; Jyrala AJ; Kloner RA
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):270-9. PubMed ID: 23345062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts.
    Wang S; Qin X; Sun D; Wang Y; Xie X; Fan W; Wang Y; Liang D; Pei X; Cao F
    Cell Biochem Funct; 2012 Oct; 30(7):574-81. PubMed ID: 22592978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival.
    Urbanek K; Rota M; Cascapera S; Bearzi C; Nascimbene A; De Angelis A; Hosoda T; Chimenti S; Baker M; Limana F; Nurzynska D; Torella D; Rotatori F; Rastaldo R; Musso E; Quaini F; Leri A; Kajstura J; Anversa P
    Circ Res; 2005 Sep; 97(7):663-73. PubMed ID: 16141414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling.
    Zeng L; Hu Q; Wang X; Mansoor A; Lee J; Feygin J; Zhang G; Suntharalingam P; Boozer S; Mhashilkar A; Panetta CJ; Swingen C; Deans R; From AH; Bache RJ; Verfaillie CM; Zhang J
    Circulation; 2007 Apr; 115(14):1866-75. PubMed ID: 17389266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.